ATE218869T1 - Verfahren zur behandlung von lebererkrankungen und ähnlichen indikationen mit vasodilatierenden wirkstoffen - Google Patents
Verfahren zur behandlung von lebererkrankungen und ähnlichen indikationen mit vasodilatierenden wirkstoffenInfo
- Publication number
- ATE218869T1 ATE218869T1 AT94926719T AT94926719T ATE218869T1 AT E218869 T1 ATE218869 T1 AT E218869T1 AT 94926719 T AT94926719 T AT 94926719T AT 94926719 T AT94926719 T AT 94926719T AT E218869 T1 ATE218869 T1 AT E218869T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- vasodilating
- ingredients
- liver diseases
- similar indications
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Gastroenterology & Hepatology (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Electrotherapy Devices (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPM110493 | 1993-09-08 | ||
| PCT/AU1994/000525 WO1995007080A1 (en) | 1993-09-08 | 1994-09-05 | A method of treating liver disease and like indications with vasodilating agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE218869T1 true ATE218869T1 (de) | 2002-06-15 |
Family
ID=3777184
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94926719T ATE218869T1 (de) | 1993-09-08 | 1994-09-05 | Verfahren zur behandlung von lebererkrankungen und ähnlichen indikationen mit vasodilatierenden wirkstoffen |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0717625B1 (de) |
| JP (1) | JP3842815B2 (de) |
| KR (1) | KR100350156B1 (de) |
| CN (1) | CN1115151C (de) |
| AT (1) | ATE218869T1 (de) |
| CA (1) | CA2170289C (de) |
| DE (1) | DE69430807T2 (de) |
| FI (1) | FI961029A (de) |
| HK (1) | HK1003422A1 (de) |
| IL (1) | IL110888A (de) |
| NO (1) | NO960866D0 (de) |
| NZ (1) | NZ273242A (de) |
| SG (1) | SG49645A1 (de) |
| WO (1) | WO1995007080A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5854233A (en) * | 1993-09-08 | 1998-12-29 | Pharmacy And Therapeutic Advisory Consultancy Ltd. | Method of treating liver disease and like indications with vasodilating agents |
| US6174917B1 (en) | 1993-09-08 | 2001-01-16 | Pharmacy And Therapeutic Advisory Consultancy Ltd. | Method of treating liver disease and like indications with vasodilating agents |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0502143B1 (de) * | 1990-09-07 | 1995-11-08 | Universidad De Alicante | Komposition für die behandlung von augenschmerzen |
| ZA923474B (en) * | 1991-05-20 | 1993-01-27 | Marion Merrell Dow Inc | Diltiazem formulation |
-
1994
- 1994-09-05 JP JP50835595A patent/JP3842815B2/ja not_active Expired - Fee Related
- 1994-09-05 DE DE69430807T patent/DE69430807T2/de not_active Expired - Fee Related
- 1994-09-05 AT AT94926719T patent/ATE218869T1/de not_active IP Right Cessation
- 1994-09-05 CA CA002170289A patent/CA2170289C/en not_active Expired - Fee Related
- 1994-09-05 KR KR1019960701141A patent/KR100350156B1/ko not_active IP Right Cessation
- 1994-09-05 NZ NZ273242A patent/NZ273242A/en unknown
- 1994-09-05 WO PCT/AU1994/000525 patent/WO1995007080A1/en active IP Right Grant
- 1994-09-05 CN CN94193320A patent/CN1115151C/zh not_active Expired - Fee Related
- 1994-09-05 SG SG1996002734A patent/SG49645A1/en unknown
- 1994-09-05 EP EP94926719A patent/EP0717625B1/de not_active Expired - Lifetime
- 1994-09-08 IL IL11088894A patent/IL110888A/xx not_active IP Right Cessation
-
1996
- 1996-03-04 NO NO960866A patent/NO960866D0/no not_active Application Discontinuation
- 1996-03-06 FI FI961029A patent/FI961029A/fi unknown
-
1998
- 1998-03-24 HK HK98102526A patent/HK1003422A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| KR100350156B1 (ko) | 2003-02-14 |
| EP0717625A4 (de) | 1997-12-29 |
| EP0717625B1 (de) | 2002-06-12 |
| CN1130874A (zh) | 1996-09-11 |
| FI961029A0 (fi) | 1996-03-06 |
| FI961029A (fi) | 1996-03-06 |
| EP0717625A1 (de) | 1996-06-26 |
| DE69430807D1 (de) | 2002-07-18 |
| DE69430807T2 (de) | 2002-12-19 |
| JPH09502188A (ja) | 1997-03-04 |
| IL110888A (en) | 1999-07-14 |
| IL110888A0 (en) | 1994-11-28 |
| CA2170289A1 (en) | 1995-03-16 |
| CN1115151C (zh) | 2003-07-23 |
| NZ273242A (en) | 2001-04-27 |
| SG49645A1 (en) | 1999-10-19 |
| JP3842815B2 (ja) | 2006-11-08 |
| CA2170289C (en) | 2001-05-08 |
| HK1003422A1 (en) | 1998-10-30 |
| NO960866L (no) | 1996-03-04 |
| NO960866D0 (no) | 1996-03-04 |
| WO1995007080A1 (en) | 1995-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE221377T1 (de) | Verfahren zur reduzierung der körperfettanteils bei tieren mit der verabreichungvon konjugiergter linolsäure | |
| ATE340581T1 (de) | Verfahren zur behandlung von prostaterkrankungen unter verwendung von vitamin-d-formulierungen mit verzögerter und/oder verlängerter wirkstofffreigabe | |
| ATE113834T1 (de) | Zusammensetzung zur behandlung der schizophrenie. | |
| ATE62414T1 (de) | Mittel zur behandlung von herzerkrankungen. | |
| ATE198050T1 (de) | Therapeutische anwendungen von bpi-protein- produkten zur behandlung von humaner meningococcämia | |
| DE69116380T2 (de) | Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit | |
| DE69836139D1 (de) | Verfahren zur behandlung von vaskulären proliferativen erkrankungen mit p27 und fusionen davon | |
| EE9900428A (et) | Köhavastased ravimkoostised | |
| ATE133859T1 (de) | Pharmazeutische zubereitungen mit verzögerter freisetzung zur behandlung periodontaler erkrankungen | |
| ATE222109T1 (de) | Kombiniertes therapeutisches verfahren zur behandlung von hyperproliferativen krankheiten | |
| ATE218869T1 (de) | Verfahren zur behandlung von lebererkrankungen und ähnlichen indikationen mit vasodilatierenden wirkstoffen | |
| ATE311897T1 (de) | Behandlung von multiplersklerose mit einer kombination von interferon und wachstumshormone | |
| KR100488038B1 (ko) | 기관 보호 활성을 지닌 신규한 신체 보호 화합물 펩티드염, 이의 제조 방법 및 치료에서의 이의 용도 | |
| DE3687233T2 (de) | Pharmazeutische zusammensetzungen zur behandlung von hautkrankheiten. | |
| DE69734349D1 (de) | Behandlung von knochenleiden mit adrenomedullin | |
| ATE147978T1 (de) | Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit | |
| ATE295731T1 (de) | Olanzapine zur behandlung von drogenmissbrauch | |
| DE68908445T2 (de) | Mittel zur Behandlung von Lebererkrankungen. | |
| DE69813354D1 (de) | Mittel zur Behandlung von Herzkrankheiten | |
| DE68905479T2 (de) | Transdermate magensafthemmende wirkstoffe zur behandlung von magen-darm-erkrankungen. | |
| ATE81587T1 (de) | Medizinisches praeparat zur behandlung von hautleiden. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |